RxDoctor Payments Data

Melissa Phillips, MD

Family Medicine · Ringgold, GANPI 1841277423

Payments from drug & device makers

$6,634in general payments, 2019–2025

Across 424 payments — averaging $15.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$664
  • Sanofi-aventis U.S. LLC$555
  • GSK$454
  • AbbVie$452
  • Novo Nordisk$446
  • Abbott$407
  • plus $4K from 39 others

What the payments were for

  • Food & beverage$6,634100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,634 in reported general payments places this provider in the 85th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$53,985
Medicare patients
212
Services billed
993

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide38$61,500
FarxigaDapagliflozin Propanediol42$38,426
JanuviaSitagliptin Phosphate41$36,567
JardianceEmpagliflozin33$32,621
EliquisApixaban34$31,640
Tresiba Flextouch U-200Insulin Degludec24$30,962
TrulicityDulaglutide13$17,169
MounjaroTirzepatide14$14,215
MyrbetriqMirabegron12$11,699
Breo ElliptaFluticasone/Vilanterol17$9,138
Rosuvastatin Calcium291$3,564
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,581
Diclofenac Sodium ErDiclofenac Sodium35$1,981
Levothyroxine Sodium229$1,887
Albuterol Sulfate HfaAlbuterol Sulfate68$1,823

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$446$61,50038 claims
AstraZenecaFarxiga$192$38,42642 claims
MerckJanuvia$159$36,56741 claims
Boehringer IngelheimJardiance$350$32,62133 claims
PfizerEliquis$664$31,64034 claims
Lilly USA, LLCTrulicity, Mounjaro$299$31,38427 claims
Astellas Pharma US IncMyrbetriq$367$11,69912 claims
GSKBreo Ellipta$454$9,13817 claims
AbbVieSynthroid$452$84117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Ringgold

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →